Primary Cutaneous B-Cell Non-Hodgkin Lymphoma

Primary Cutaneous B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: Mayo Clinic
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–20 of 20 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02213913	Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas	completed	Phase 1 / Phase 2	55	University of ChicagoOTHER	1	Mar 11, 2026	clinicaltrials
NCT01258998	Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma	completed	Phase 2	60	National Cancer Institute (NCI)NIH	1	Nov 4, 2020	clinicaltrials